ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 100 filers reported holding ADMA BIOLOGICS INC in Q3 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114 | +46.2% | 31,975 | +50.4% | 0.01% | +10.0% |
| Q2 2023 | $78 | +100.0% | 21,255 | +81.5% | 0.01% | +150.0% |
| Q1 2023 | $39 | -99.9% | 11,713 | -63.4% | 0.00% | -33.3% |
| Q1 2021 | $56,000 | +40.0% | 31,982 | +55.5% | 0.01% | 0.0% |
| Q4 2020 | $40,000 | -60.8% | 20,562 | -51.9% | 0.01% | -62.5% |
| Q3 2020 | $102,000 | -7.3% | 42,787 | +13.9% | 0.02% | -5.9% |
| Q2 2020 | $110,000 | – | 37,569 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
| Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
| Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
| AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
| Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
| Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
| Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
| TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
| EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |